Physician

Varghese Parambi, MD

According to 2025 Medicare claims, Varghese Parambi, MD (NPI: 1386645257) practices nephrology in the Great Falls, MT market, with the plurality of this provider's patient population coming from Cascade, MT. This provider's primary affiliated billing organization is BENEFIS HOSPITALS INC (NPI: 1780968974; TIN: 810232122) and primary practice location at 59405-3473. Parambi is affiliated with the Caravan Health ACO 50 LLC (ACO ID: A5160), participating under the MSSP model.

Parambi's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 351 traditional Medicare patients, billed 1,948 HCPCS/CPT codes, and received $238,285 in Medicare payments. The top billing code was 90961 (Dialysis services, 2-3 physician visits per month (20 years or older)). Part D data shows 1,871 prescription claims across 236 beneficiaries totaling $177,000 in drug costs, led by Jardiance (Empagliflozin). DME data shows 762 claims. No Open Payments records. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have moved from a higher plateau to a lower plateau, from $324,347 to $177,000. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	732	3,216	$307,963
2016	721	2,980	$300,242
2017	663	2,586	$279,396
2018	622	2,395	$275,418
2019	483	2,449	$282,192
2020	416	2,420	$302,585
2021	448	2,604	$335,747
2022	383	2,306	$282,063
2023	391	1,901	$249,360
2024	351	1,948	$238,285

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	307	2,957	$324,347
2016	324	3,328	$339,904
2017	322	3,451	$506,154
2018	328	3,188	$298,613
2019	311	2,686	$357,044
2020	230	2,252	$237,671
2021	225	2,042	$225,065
2022	205	1,849	$191,857
2023	187	1,766	$188,692
2024	236	1,871	$177,000

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	63	500	$31,107
2016	61	653	$27,384
2017	47	559	$20,900
2018	77	855	$40,596
2019	77	902	$37,612
2020	46	778	$26,172
2021	69	984	$33,500
2022	57	872	$22,987
2023	49	770	$13,809
2024	67	762	$17,667

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
90961	Dialysis services, 2-3 physician visits per month (20 years or older)	48	156	$217
90962	Dialysis services, 1 physician visit per month (20 years or older)	43	191	$148
99223	Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes	84	89	$133
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	192	336	$72
99232	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes	122	631	$61

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Jardiance	Empagliflozin	36	1,184	$22,277
Cinacalcet Hcl	Cinacalcet Hcl	26	1,140	$20,562
Lokelma	Sodium Zirconium Cyclosilicate	14	953	$13,404
Eliquis	Apixaban	13	690	$12,749
Sevelamer Carbonate	Sevelamer Carbonate	100	3,724	$11,969

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
J7527	Everolimus, oral, 0.25 mg	N	N/R	11	$5,453
Q0512	Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for a subsequent prescription in a 30-day period	N	17	199	$3,023
J7518	Mycophenolic acid, oral, 180 mg	N	N/R	60	$2,813
Q0511	Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for the first prescription in a 30-day period	N	21	166	$2,785
J7507	Tacrolimus, immediate release, oral, 1 mg	N	17	169	$2,400

Open Payments Summary

No connected Open Payments records were found for this physician in General Payments, Research Payments, or Ownership / Investment Interests.

Explore More Providers

FAQ

What Medicare data is available for Varghese Parambi, MD?

Tedicare shows public-source Medicare data for Varghese Parambi, MD (NPI 1386645257), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Varghese Parambi, MD have ACO affiliation data?

Varghese Parambi, MD is shown with ACO affiliation data for Caravan Health ACO 50 LLC (MSSP, ACO ID A5160).

What billing organization is linked to Varghese Parambi, MD?

Varghese Parambi, MD is linked to BENEFIS HOSPITALS INC (billing NPI 1780968974) in the available physician profile data.

Does Varghese Parambi, MD have Open Payments data?

No connected Open Payments records are shown for this physician in the available General Payments, Research Payments, or Ownership / Investment Interests data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.